Breast Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

By Type (Imaging, Biopsy, Genomic Tests, Blood Tests, Others), By Product (Platform-based Products (Next-generation Sequencing, Microarrays, PCR, Others), Instrument-based Products (Imaging, Biopsy)), By Application (Screening, Diagnostic and Predictive, Prognostic, Research, Others), By End-use (Hospitals & Clinics, Diagnostic Centers and Medical Laboratories, Others), By Region, and By Competition

Published	Pages	Publisher	Report code
Feb 2024	180	TechSci Research	ASDR-657586

Published: Feb 2024 - Pages : 180 - Publisher : TechSci Research - Report code : ASDR-657586

1. Hologic Inc
2. Genomic Health Inc
3. Becton Dickinson & Co Ltd
4. Danaher Corp
5. Koninklijke Philips NV
6. QIAGEN NV
7. Thermo Fisher Scientific Inc
8. Myriad Genetics Inc
9. Argon Medical Devices Inc
10. F Hoffmann-La Roche AG

Asia-Pacific Next-Generation Breast Cancer Diagnostic and Screening Market: Analysis and Forecast, 2023-2032

This report can be of interest as well:

Asia-Pacific Next-Generation Breast Cancer Diagnostic and Screening Market: Analysis and Forecast, 2023-2032

Published: February, 2024 | Report code: ASDR-657253

Mark your calendar:

Oligonucleotide Therapeutics and Delivery Conference 2024

09 September - 10 September, 2024
London, United Kingdom